Previous Close | 20.50 |
Open | 20.49 |
Bid | 0.00 x 900 |
Ask | 0.00 x 900 |
Day's Range | 19.78 - 20.56 |
52 Week Range | 11.45 - 22.32 |
Volume | 128,597 |
Avg. Volume | 79,600 |
Market Cap | 477.664M |
Beta (5Y Monthly) | 0.97 |
PE Ratio (TTM) | 3.88 |
EPS (TTM) | 5.15 |
Earnings Date | N/A |
Forward Dividend & Yield | 1.72 (8.28%) |
Ex-Dividend Date | Feb 25, 2021 |
1y Target Est | N/A |
On February 26, 2021, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $46,585,441 of which $57,287,486 represents net unrealized appreciation of portfolio securities.
On February 26, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $154,173,967 of which $157,978,325 represents net unrealized appreciation of portfolio securities.
On February 16, 2021, Tekla Life Sciences Investors declared a distribution of $0.43 per share. The record date for the distribution is February 26, 2021 and the payable date is March 31, 2021. The Fund will trade ex-distribution on February 25, 2021.